TVAX-008

· Grand Theravac Life Sciences (Nanjing) Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TVAX-008, covering 2025-09-18 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B [Phase 3]

See pricing